Showing 5191-5200 of 10638 results for "".
Exploring Novel Tools for PAH: Measuring Severity With a New Blood Test
https://reachmd.com/programs/heart-matters/exploring-novel-tools-for-pah-measuring-severity-with-a-new-blood-test/13963/Could a new blood test help us better evaluate the severity of PAH in our patients? Find out how.Exploring A New Anti-Obesity Treatment
https://reachmd.com/programs/diabetes-discourse/exploring-a-new-anti-obesity-treatment/13629/Take a look at the obesity treatment landscape—and find out more about a new anti-obesity treatment option.Study with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
https://reachmd.com/programs/acc-action-center/study-with-aso-targeting-angptl3-mrna-highlights-importance-of-rigorous-evaluation-of-new-therapies/13773/Can vupanorsen reduce non-HDL cholesterol in statin-treated patients? Hear the findings with this session recap from ACC 2022.Exploring the Treatment Landscape for Triple-Negative Breast Cancer
https://reachmd.com/programs/project-oncology/exploring-the-treatment-landscape-for-triple-negative-breast-cancer/13626/Find out what treatment options are available for your patients with triple-negative breast cancer.Insights on PsA Management
https://reachmd.com/programs/practical-dermatology/insights-on-psa-management/23665/With about one-third of psoriasis patients likely to develop joint disease, dermatologists must be prepared to comanage PsA symptoms.Bringing Barret’s Esophagus into Focus: A Look at Controversies & Unanswered Questions
https://reachmd.com/programs/gi-insights/bringing-barrets-esophagus-into-focus-a-look-at-controversies-unanswered-questions/12502/The evaluation and treatment of Barrett’s esophagus has evolved over the years. Here’s how can you properly diagnosis, evaluate, and treat it.Perspectives on Pancreatic Cysts: How to Determine Malignancy
https://reachmd.com/programs/gi-insights/perspectives-on-pancreatic-cysts-how-to-determine-malignancy/12433/Pancreatic cysts may be detected in up to 50 percent of patients undergoing intraabdominal MR imaging. How can we tell which ones are malignant?Artificial Intelligence’s Role in Combating the Antibiotic Resistance Crisis
https://reachmd.com/programs/clinicians-roundtable/artificial-intelligences-role-in-combating-the-antibiotic-resistance-crisis/11247/In an effort to find potential candidates to help combat the antibiotic resistance crisis, one research team turned to an unexpected source.Fast-Tracking Coronavirus Solutions
https://reachmd.com/programs/public-health-call/fast-tracking-coronavirus-solutions/11470/The challenges presented by the pandemic are giving rise to a pipeline of research proposals focused on COVID-19.How Is Social Media Driving Patient Education?
https://reachmd.com/programs/villanova_health_summit/how-is-social-media-driving-patient-education/10657/The reasons why your patients are using social media go far beyond getting likes or connecting with family and friends.